BSE filing, BSE: 532154. Summary written from the filing by ALFA Finder's alert engine.
Johnson Pharmacare Ltd: key numbers
- Share price
- ₹0.37
- Market cap
- ₹20.35 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-55.73 Cr
- P/E (TTM)
- -0.4×Sector 45.2×
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Johnson Pharmacare Ltd
All →Johnson Pharmacare Other Announcement
Johnson Pharmacare Limited has approved the shifting of its registered office within the local limits of Ahmedabad. This administrative change was approved at their board meeting.
Johnson Pharmacare Board Meeting Date
Johnson Pharmacare Limited has scheduled a board meeting on August 13, 2026, to consider and approve the standalone unaudited financial results for the quarter ending June 30, 2026.
Johnson Pharmacare Other Announcement
Johnson Pharmacare Ltd has submitted its quarterly shareholding pattern filing for the period ending June 30, 2026, as required by regulatory norms.
Johnson Pharmacare Management Change
Company Secretary Neha Srivastava resigned from the board effective June 11, 2026. The board acknowledges the change with no other material impact.
Johnson Pharmacare Financial Results
Johnson Pharmacare reported audited financial results for the year ended March 31, 2026. The company faces a ₹21.40 Crore debt burden and auditor qualifications regarding internal controls.
- Value
- ₹21.40 Cr
Johnson Pharmacare Financial Results
Johnson Pharmacare Limited reported annual total income of ₹1.58 Crore for FY 2025-26. The company also announced resignations of directors Rajendra Prasad and Umesh Kumar.
- Value
- ₹158.1 Cr
Other other announcement announcements
All →STL Networks Other Announcement
The Monitoring Agency reported Rs. 2 Crore utilization of Preferential Issue proceeds, with no deviations from objects. The report covers the quarter ending September 30, 2026.
HEG Advanced Materials Other Announcement
HEG Advanced Materials Limited has intimated the exchange regarding the change of its Corporate Identification Number (CIN) following an approved scheme of arrangement.
Sanofi India Other Announcement
Sanofi India issued a communication regarding Tax Deduction at Source (TDS) for the interim dividend declared for FY 2026. Shareholders must update details by November 5, 2026.
Visaka Industries Other Announcement
Visaka Industries informed the exchange about sending reminder letters to shareholders regarding the compulsory transfer of unclaimed dividends and equity shares to the IEPF account.
Arvaya Healthcare Other Announcement
Arvaya Healthcare filed its quarterly shareholding pattern under Regulation 31(1)(c). The filing reports routine ownership breakdowns with no transaction.
AYM Syntex Other Announcement
AYM Syntex's board appointed BSR & Co. LLP as statutory auditor for five years, subject to shareholder approval. Routine auditor appointment; no monetary value involved.
- Execution
- Five consecutive years, from the conclusion of the 44th AGM to the conclusion of the 49th AGM